cells are widely distributed, which can be stored in
advance, and also highly proliferative and
multipotential, so they can be one of the best seed
cells to replace autologous hematoma cells
transplantation for the treatment of fracture healing
[6]
. In recent years, the proliferation of in vitro cell
culture is increasingly mature, which makes it
possible to proliferate a large number of primary
cells in the short term and can be reserved for a long
time. In theory, it is considered that the fracture
hematoma cell is a relatively primitive cell with
weak antigenicity. Therefore, allograft
transplantation may cause mild or even no immune
rejection. But up to now, no specific experimental
study at home and abroad was reported.
Schuurman et al. [7] divided xenograft rejection
in the early stage into three categories: hyperacute
rejection (HAR), acute humoral xenograft rejection
(AHXR), and acute cellular xenograft rejection
(ACXR). Studies have shown that the graft non-
function were mainly due to the hyperacute rejection
and the acute dissimilar rejection of the body fluid.
Hyperacute rejection is a leading cause which occurs
within 24 hours after transplantation, It is mainly the
antibody mediated mechanism, which is the humoral
immune response caused by the natural antibody
IgM, and the natural antibody IgG also plays a
certain role[8-10]. Dehoux [11] suggests that anti
IgM and IgG play an important role in activating
endothelial cells and complement. Especially the
induction of anti -Gal IgG is significantly elevated in
AHXR, which may play a major role. The diagnostic
criteria for antibody - mediated acute graft rejection
include 3 basic characteristics [12]: (1)
morphological evidence for acute tissue injury. (2)
immunological evidence of antibody action. (3)
Serological evidence of circulating donor specific
human leukocyte antigen (HLA) antibody or other
donor epithelial cells antigen specific antibodies.
One of the characteristics of AHXR is the
infiltration of all kinds of cells to the grafts. The
existence of neutrophils has a certain predictability
in the diagnosis of AR, and it may represent early
immune response is activated [13-15].
Fischbeck[16] study shows that DXR is mediated by
immune cells such as mononuclear cells.
Mononuclear phagocyte system responsible for
recognition and rejection of xenogeneic antigen in
xenotransplantation [17]; The lymphoid follicles in
the spleen increases when the antigen and blood
circulation enters the spleen and causes humoral
immune response [18]. The results showed that after
the ordinary rabbits hematoma cells were
transplanted into New Zealand rabbits fracture of 1
days、 4 days and 8 days after transplantation, a
large number of xenohematomas survived in the
transplanted region, no obvious degeneration and
necrosis were found and no obvious IgM and IgG
deposition was found around the broken end of the
fracture. There was no significant difference in the
infiltration of neutrophils and CD68 positive
macrophages in the fracture area between each
group in different time. At the same time, there was
no significant difference in the number of splenic
lymphoid follicles in and between groups at different
time, and no significant proliferation of the splenic
lymphoid follicles was found. All these indicate that
there is no obvious rejection reaction between
transplanted rabbit xenogeneic hematoma cells and
their receptors in early stage, and good
histocompatibility also imply that allogeneic
hematoma cells transplantation is feasible, which
provides an experimental basis for future treatment
of fractures or bone defects.
REFERENCES
1. Mizuno K,Mineo K,Tachibana T,et al.The
osteogenetic potential of fracture
haematoma.Subperiosteal and intramuscular
transplantation of the haematoma[J].J Bone Joint
Surg(Br) 1990,72(5):822-9.
2. Guo Hongwang,Li Yuxue. Reutilization of
hematoma at fracture site [J]. China Journal of
Orthopaedics and Tyaumatology,2001,14(1):50-51.
3. Guo Q, Liu Z, Zhanqing L I. Technical explore on
mesenchymal stem cells in bone marrow using BrdU
labelling[J]. Journal of North China Coal Medical
College, 2004,6(1):4-7.
4. Guo Qicang,Zhang Yu,Wang Yufang.
Characteristics and feasibility of bone marrow-
derived mesenchymal stem cells labeled with 5-
bromodexyuridine[J].Chinese Journal of Clinical
Rehabilitation,2006,10(5):144-146.
5. Li Guitao, Li Huaren, Xu Hongzhang. Experiment
Study of the Osteogenetic Potential of Bone
Hematoma[J].Chinese Journal of Bone and Joint
Injury , 2004,19(5):323-324.
6. Grundnes O, Reikers O. The importance of the
hematoma for fracture healing in rats[J]. Acta
Orthopaedica Scandinavica, 1993, 64(3):340-2.
7. SchuurmanHJ,PinoCG,PhllipsMJ,et al.Incidence of
hyperacute rejection In pig-to primate
transplantation using organs from hDAF-transgenic
donors.Transplantation,2002,73(6),1146-1157
8. Koren E, Neethling F A, Richards S, et al. Binding
and specificity of major immunoglobulin classes of
preformed human anti-pig heart antibodies[J].
Transplant International, 1993, 6(6):351.